Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Five Oxford Clinical Medical Students place in top 10% in prestigious national Ophthalmology Duke Elder Prize Examination

Image courtesy of Shutterstock

Fifth year Clinical Medical student, Mr John Logan (St Edmund Hall), gained an impressive 14th place in the Royal College of Ophthalmology's annual Prize Examination. Mr Logan was one of 370 medical students from 38 medical schools across the UK and Ireland who took the exam this year. In addition, Mr Benjamin Ng (5th Year/Christ Church College) and Mr Alexander Noar (6th Year/St John’s College), were both ranked 17th and Miss Anni Ding (6th Year/St John’s College) and Mr Dun Jack Fu (Graduate Entry 4th Year/St Hugh’s College) were placed in the top 10%.

The Royal College of Ophthalmology advise that the standard of the exam is deliberately high and those students taking the top places are to be congratulated. The names of students gaining a top 20 place are published and the candidate gaining the highest mark is offered the chance to visit St John’s Eye Hospital in Jerusalem or a monetary prize of £400. 

Questions are mostly based on clinical ophthalmology but other areas covered include ocular physiology, anatomy and pathology as well as genetics of eye conditions and socio-economic medicine relevant to ophthalmology  (for example, blind registration or world blindness).  In the clinical questions all the sub-speciality areas within ophthalmology are covered.

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.